Edition:
United States

Ventas Inc (VTR.N)

VTR.N on New York Stock Exchange

64.24USD
22 Nov 2017
Change (% chg)

$-0.08 (-0.12%)
Prev Close
$64.32
Open
$64.31
Day's High
$64.55
Day's Low
$64.11
Volume
259,399
Avg. Vol
398,941
52-wk High
$72.34
52-wk Low
$57.97

Latest Key Developments (Source: Significant Developments)

Ventas reports Q3 adjusted FFO per share $1.04
Friday, 27 Oct 2017 06:56am EDT 

Oct 27 (Reuters) - Ventas Inc :Ventas reports 2017 third quarter results.Q3 adjusted FFO per share $1.04.Qtrly ‍normalized funds from operations per diluted common share $1.04​.Qtrly ‍ reported FFO per diluted common share for $1.02​.Ventas Inc - ‍Company expects to invest in future growth by funding approximately $300 million in development and redevelopment projects for full year 2017​.Ventas Inc sees full year income from continuing operations per diluted common share to range between $1.63 and $1.74​.Ventas Inc - Q3 2017 same-store total portfolio (1,045 assets) cash net operating income grew 2.1 percent compared to same period in 2016​.Ventas Inc - ‍Company projects FY normalized FFO per diluted common share to now range between $4.13 and $4.16​.Ventas Inc - Sees ‍nareit FFO per diluted common share to range between $4.07 and $4.12​.Ventas Inc sees ‍2017 same-store cash noi growth for total company between 2% to 2.5%​.  Full Article

Ventas announces Lillibridge Healthcare Services CEO transition
Friday, 28 Jul 2017 07:10am EDT 

July 28 (Reuters) - Ventas Inc :Ventas Inc - ‍Todd W. Lillibridge to transition out of top executive role in early 2018​.Ventas Inc - ‍Ventas intends to appoint a new leader of MOB business and will commence search process promptly​.Ventas Inc - ‍Lillibridge will transition to a new role as senior advisor to Ventas chairman and CEO in early 2018​.  Full Article

Ventas reports 2017 second quarter results
Friday, 28 Jul 2017 07:09am EDT 

July 28 (Reuters) - Ventas Inc :Q2 adjusted FFO per share $1.06.Q2 earnings per share $0.42 from continuing operations.Q2 earnings per share view $0.45 -- Thomson Reuters I/B/E/S.Ventas Inc - ‍reaffirms previously announced 2017 guidance​.Ventas Inc - ‍continues to expect that it will sell 36 skilled nursing facilities that are currently operated by Kindred Healthcare Inc​.Ventas Inc qtrly reported FFO per diluted common share ("NAREIT FFO"), totaled $1.04.Ventas Inc - ‍expected gross proceeds to Ventas are $700 million from Kindred Healthcare​ deal.Ventas - continues to expect to invest in future growth by funding approximately $350 million in development and redevelopment projects for full year 2017​.Ventas Inc - ‍Ventas expects to use proceeds from sale to Kindred Healthcare to repay debt​.Ventas Inc - company's Q2 2017 same-store total portfolio (1,114 assets) cash NOI grew 1.5 percent compared to same period in 2016.FY2017 earnings per share view $1.81, revenue view $3.51 billion -- Thomson Reuters I/B/E/S.FY2017 FFO per share view $4.18 -- Thomson Reuters I/B/E/S.Q2 FFO per share view $1.05 -- Thomson Reuters I/B/E/S.  Full Article

Ventas reaffirms expected sale of 36 skilled nursing facilities for $700 mln
Friday, 30 Jun 2017 09:02pm EDT 

June 30 (Reuters) - Ventas Inc :Ventas reaffirms expected sale of 36 skilled nursing facilities for $700 million to facilitate kindred healthcare’s exit from its skilled nursing segment.Ventas skilled nursing portfolio will represent only one percent of net operating income upon sale.Kindred expects closings of sale of Ventas SNFs to occur in phases, beginning in Q3 of 2017 and completed by year end 2017.  Full Article

Kindred reaches agreement with BM Eagle to sell its skilled nursing facility business for $700 mln
Friday, 30 Jun 2017 08:55pm EDT 

June 30 (Reuters) - Kindred Healthcare Inc :Kindred announces definitive agreement to divest skilled nursing facility business.Total value to kindred will approximate $910 million.Kindred will retain working capital, owned Las Vegas nursing center and hospital-based sub-acute units.Expects phased transaction closings to begin in Q3 of 2017 and be completed by year end 2017.Kindred expects phased transaction closings to begin in Q3 of 2017 and be completed by year end 2017.Following sale, annual rent expense to be reduced by about $88 million, annual capex to be reduced by about $30 million.Following sale, annual noncontrolling interests payments will be reduced by approximately $18 million.Signed agreement with bm eagle under which will sell company's skilled nursing facility business for $700 million in cash.Expects to realize net value of approximately $210 million, subject to post-closing adjustments, and after $700 million payment to ventas."Expect exiting skilled nursing facility business will increase kindred's annual cash flow by approximately $20 million to $30 million".Signed definitive agreement with BM Eagle Holdings to sell company's skilled nursing facility business.Guggenheim securities is acting as financial advisor to kindred.Company estimates accounting change will reduce Q2 reported core EBITDAR from continuing operations by approximately $35 million.  Full Article

Ventas prices Cdn$275 mln of senior notes due 2023
Thursday, 25 May 2017 05:20pm EDT 

May 25 (Reuters) - Ventas Inc :Ventas prices cdn$275 million of 2.55% senior notes due 2023.Ventas inc - ‍notes will mature on march 15, 2023​.Ventas inc - interest on notes will be payable semi-annually on march 15 and september 15 of each year, commencing on september 15, 2017.  Full Article

Ventas Inc says units entered into a second amended and restated credit and guaranty agreement - sec filing
Friday, 28 Apr 2017 07:55am EDT 

April 28 (Reuters) - Ventas Inc :Ventas Inc - on April 25 units entered into a second amended and restated credit and guaranty agreement - SEC filing.Ventas - new credit agreement provides for $3.0 billion unsecured revolving credit facility, evidences $200 million unsecured term loan facility maturing in 2018.Ventas Inc- new credit agreement replaces company's existing unsecured credit facility.Ventas Inc - new credit agreement also evidences$800 million unsecured term loan facility maturing in 2019.Ventas Inc - aggregate borrowing capacity under new credit agreement may be increased, at borrowers' option, to up to $3.75 billion.Ventas Inc - revolving credit facility matures on April 25, 2021.Ventas Inc - 2018 term facility matures on January 31, 2018, and 2019 term facility matures on January 31, 2019.  Full Article

Ventas Inc Q1 EPS $0.44 from continuing operations
Friday, 28 Apr 2017 07:01am EDT 

April 28 (Reuters) - Ventas Inc :Ventas reports 2017 first quarter results.Q1 earnings per share $0.44 from continuing operations.Ventas Inc says 2017 guidance consistent with previously announced company expectations.Ventas Inc says expects to invest in future growth by funding approximately $350 million in development and redevelopment projects for full year 2017.Qtrly normalized funds from operations per diluted common share totaled $1.03.Q1 FFO per share view $1.02 -- Thomson Reuters I/B/E/S.Ventas Inc - company's Q1 2017 same-store total portfolio (1,175 assets) cash NOI growth was 3.9 percent compared to same period in 2016..2017 guidance confirmed.Fy2017 FFO per share view $4.17 -- Thomson Reuters I/B/E/S.  Full Article

Ventas announces pricing of senior notes
Wednesday, 22 Mar 2017 04:59pm EDT 

Ventas Inc : Ventas announces pricing of senior notes . Ventas Inc - Pricing of public offering of $400 million aggregate principal amount of 3.10% senior notes due 2023 .Ventas Inc - Pricing of public offering of $400 million aggregate principal amount of 3.85% senior notes due 2027.  Full Article

Ventas Inc says buys medical campus in Rhode Island
Tuesday, 14 Mar 2017 05:56pm EDT 

Ventas Inc : Says purchased life science, research and medical campus in Providence, Rhode Island from affiliates of Blackstone Real Estate Partners VIII . Expects investment to be accretive to 2017 normalized funds from operations per share . Ventas funded transaction using cash on hand and other capital sources .Deal for nearly $130 million.  Full Article

BRIEF-Ventas reports Q3 adjusted FFO per share $1.04

* Qtrly ‍normalized funds from operations per diluted common share $1.04​